Intellectual Property India Publishes Patent Application for 'RNA Molecules Encoding RSV-F And Vaccines Containing Them' Filed by Pfizer Inc.

MUMBAI, India, May 16 -- Intellectual Property India has published a patent application (202517040292 A) filed by Pfizer Inc., New York, on April 25, for 'rna molecules encoding rsv-f and vaccines containing them.'

Inventor(s) include Chen, Wei; Diaz, Fernando Martin; and Swanson, Kena Anne.

The application for the patent was published on May 16, under issue no. 20/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure relates to RNA molecules encoding a respiratory syncytial virus (RSV). The present disclosure further relates to compositions comprising the RNA molecules formulated in a lipid nanoparticle (RNA-LNP). The present disclosure further relates to the use of the RNA molecules, RNA-L...